In pediatric patients (0-17y/o) , how does the use of tele medicine visits ( direct to consumer) for upper respiratory (URI) compared with in-person visits results in higher rates of antibiotics being given from 2015 to 2019 ?

In pediatric patients (0-17y/o) , how does the use of tele medicine visits ( direct to consumer) for upper respiratory (URI) compared with in-person visits results in higher rates of antibiotics being given from 2015 to 2019 ?

In pediatric patients (0-17y/o) , how does the use of tele medicine visits ( direct to consumer) for upper respiratory (URI) compared with in-person visits results in higher rates of antibiotics being given from 2015 to 2019 ?
Scroll to top